• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N,N-双(2-氯乙基)-二氨基磷酸对肿瘤细胞的通透性(作者译)

[Permeability of N,N-bis(2-chloroethyl)-diamido-phosphoric-acid into tumor cells (author's transl)].

作者信息

Lenssen U, Hohorst H J

出版信息

J Cancer Res Clin Oncol. 1979 Feb 19;93(2):161-4. doi: 10.1007/BF00406573.

DOI:10.1007/BF00406573
PMID:438280
Abstract

The uptake of tritiated N,N-bis(2-chloroethyl)-diamido-phosphoric-acid into Ehrlich-Ascites-Tumor cells of mice was studied by means of the siliconoil-filtration technique. At 10 mM concentration no permeation of the metabolite into the tumor cells could be found within 5 min at 1 degrees C, while its congenors cyclophosphamide and 4-hydroperoxycyclophosphamide (1 mM) were shown to permeate into the cells very easily reaching saturation values. Thus lack of permeation into tumor cells of N,N-bis(2-chloroethyl)-diamidophosphoric-acid seems to be the reason for the poor cytotoxic activity of this metabolite of cyclophosphamide.

摘要

采用硅油过滤技术研究了氚标记的N,N-双(2-氯乙基)-二氨基磷酸进入小鼠艾氏腹水癌细胞的情况。在10 mM浓度下,在1℃时5分钟内未发现该代谢产物渗透进入肿瘤细胞,而其同类物环磷酰胺和4-氢过氧环磷酰胺(1 mM)很容易渗透进入细胞并达到饱和值。因此,N,N-双(2-氯乙基)-二氨基磷酸缺乏渗透进入肿瘤细胞的情况似乎是环磷酰胺这种代谢产物细胞毒性活性较差的原因。

相似文献

1
[Permeability of N,N-bis(2-chloroethyl)-diamido-phosphoric-acid into tumor cells (author's transl)].N,N-双(2-氯乙基)-二氨基磷酸对肿瘤细胞的通透性(作者译)
J Cancer Res Clin Oncol. 1979 Feb 19;93(2):161-4. doi: 10.1007/BF00406573.
2
Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice.环磷酰胺代谢产物在大鼠肝微粒体系统及小鼠体内与DNA的结合
Cancer Res. 1985 Sep;45(9):4237-43.
3
Permeation of cyclophosphamide (NSC-26271) metabolites into tumor cells.
Cancer Treat Rep. 1976 Apr;60(4):423-7.
4
[Antitumor activity of 2,6-bis(halomethyl)piperidines on Ehrlich ascites carcinoma (author's transl)].2,6-双(卤甲基)哌啶对艾氏腹水癌的抗肿瘤活性(作者译)
Yakugaku Zasshi. 1977 Oct;97(10):1150-4. doi: 10.1248/yakushi1947.97.10_1150.
5
[The difference of drug sensitivity of tumor cells on N-ethyloxycarbonylaminomethyl-L-isoleucine (A-145 (author's transl)].
Nihon Yakurigaku Zasshi. 1979 Jan;75(1):53-9. doi: 10.1254/fpj.75.53.
6
[On structure-activity relationships of N'methyl-N'-beta-chloroethyl-benzaldehyde hydrazones (author's transl)].关于N-甲基-N-β-氯乙基苯甲醛腙的构效关系(作者译)
Arzneimittelforschung. 1977;27(11):2114-7.
7
5-Fluoro- and 5-chlorocyclophosphamide: synthesis, metabolism, and antitumor activity of the cis and trans isomers.5-氟和5-氯环磷酰胺:顺式和反式异构体的合成、代谢及抗肿瘤活性
J Med Chem. 1981 Dec;24(12):1399-403. doi: 10.1021/jm00144a006.
8
Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.双功能催化介导4-氢过氧环磷酰胺和4-羟基环磷酰胺转化为磷酰胺芥和丙烯醛。
Cancer Res. 1982 Mar;42(3):830-7.
9
[Zn-transport in ascites tumour cells (author's transl)].
Z Klin Chem Klin Biochem. 1971 Sep;9(5):438-42.
10
Antitumor activity of an alkylating derivative of dipyridamole.双嘧达莫烷基化衍生物的抗肿瘤活性
Anticancer Res. 1996 Jul-Aug;16(4A):1831-3.

引用本文的文献

1
CYP3A4, CYP2C9 and CYP2B6 expression and ifosfamide turnover in breast cancer tissue microsomes.乳腺癌组织微粒体中CYP3A4、CYP2C9和CYP2B6的表达及异环磷酰胺的代谢转化
Br J Cancer. 2004 Feb 23;90(4):911-6. doi: 10.1038/sj.bjc.6601492.
2
[Blood level and urinary excretion of activated cyclophosphamide and its deactivation products in man (author's transl)].人体内活化环磷酰胺及其失活产物的血药浓度和尿排泄情况(作者译)
J Cancer Res Clin Oncol. 1980 Jan;96(1):79-92. doi: 10.1007/BF00412899.
3
Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.

本文引用的文献

1
Adenine nucleotide translocation of mitochondria. 1. Specificity and control.线粒体腺嘌呤核苷酸转运。1. 特异性与调控
Eur J Biochem. 1968 Oct 17;6(1):66-79. doi: 10.1111/j.1432-1033.1968.tb00420.x.
2
Urinary metabolites of the antitumor agent cyclophosphamide.抗肿瘤药物环磷酰胺的尿液代谢产物。
Mol Pharmacol. 1971 Sep;7(5):519-29.
3
Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide.一些关于环磷酰胺和异环磷酰胺微粒体代谢过程中形成的活性中间体的研究。
异环磷酰胺氮芥,异环磷酰胺的一种代谢产物,其对鼠肿瘤的活性与环磷酰胺相当。
Br J Cancer. 1983 Jan;47(1):15-26. doi: 10.1038/bjc.1983.2.
4
Brain and plasma pharmacokinetics and anticancer activities of cyclophosphamide and phosphoramide mustard in the rat.环磷酰胺和磷酰胺芥在大鼠体内的脑和血浆药代动力学及抗癌活性
Cancer Chemother Pharmacol. 1990;27(1):1-7. doi: 10.1007/BF00689268.
Biochem Pharmacol. 1974 Jan 1;23(1):115-29. doi: 10.1016/0006-2952(74)90318-9.
4
Permeation of cyclophosphamide (NSC-26271) metabolites into tumor cells.
Cancer Treat Rep. 1976 Apr;60(4):423-7.
5
The problem of oncostatic specificity of cyclophosphamide (NSC-26271): Studies on reactions that control the alkylating and cytotoxic activity.环磷酰胺(NSC - 26271)的肿瘤生长抑制特异性问题:关于控制烷基化和细胞毒性活性反应的研究
Cancer Treat Rep. 1976 Apr;60(4):309-15.
6
Identification of phosphorodiamidic acid mustard as a human metabolite of cyclop hosphamide.
Cancer Res. 1975 Jun;35(6):1453-7.